NASDAQ: CELZ
Creative Medical Technology Holdings Inc Stock Ownership - Who owns Creative Medical Technology Holdings?

Insider buying vs selling

Have Creative Medical Technology Holdings Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Michael H. FingerDirector2025-02-19750$5.75
$4.31kSell
Michael H. FingerDirector2025-02-18750$5.00
$3.75kSell

1 of 1

CELZ insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CELZ insiders and whales buy or sell their stock.

CELZ Shareholders

What type of owners hold Creative Medical Technology Holdings Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Timothy Warbington1.35%34,904$65.97kInsider
Vanguard Group Inc1.00%25,868$48.89kInstitution
Geode Capital Management LLC0.90%23,256$43.95kInstitution
Drw Securities LLC0.59%15,101$28.54kInstitution
Allworth Financial LP0.16%4,000$7.56kInstitution
Osaic Holdings Inc0.04%1,130$2.14kInstitution
Jones Financial Companies LLLP0.04%1,000$1.89kInstitution
Michael H. Finger0.01%351$663.39Insider
Fmr LLC0.01%200$378.00Institution
Bank Of America Corp0.01%131$247.59Institution

1 of 2

CELZ vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CELZ2.74%1.37%Net Selling
CYCN6.59%72.50%Net Buying
BGMS0.01%99.99%Net Selling
GNPX20.95%79.05%Net Selling
SLXN0.08%99.92%Net Buying

Creative Medical Technology Holdings Stock Ownership FAQ

Who owns Creative Medical Technology Holdings?

Creative Medical Technology Holdings (NASDAQ: CELZ) is owned by 2.74% institutional shareholders, 1.37% Creative Medical Technology Holdings insiders, and 95.89% retail investors. Timothy Warbington is the largest individual Creative Medical Technology Holdings shareholder, owning 34,904.00 shares representing 1.35% of the company. Timothy Warbington's Creative Medical Technology Holdings shares are currently valued at $63.87k.

If you're new to stock investing, here's how to buy Creative Medical Technology Holdings stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.